It is essential that a substance and its delivery system are optimally compatible. Biotechnology drugs, in particular, contain highly sensitive active ingredients that can interact with the drug-delivery system. Other considerations include a drug's sensitivity to oxygen or to the silicone that coats the inside of a syringe to lubricate the plunger.
Vetter Development Service specialises in taking complex compounds from preclinical development through market launch. In close collaboration with its customers, Vetter selects:
During manufacture, state-of-the-art technology and methods minimise loss of active ingredient. To help prevent surprises at market production, commercial manufacturing processes are replicated in early-stage laboratories. At phase III, products are transferred to Vetter Commercial Manufacturing for large-scale filling.
Vetter Development Service provides: